Literature DB >> 28591469

Continued decline in blood collection and transfusion in the United States-2015.

Katherine D Ellingson1,2, Mathew R P Sapiano1,3, Kathryn A Haass1, Alexandra A Savinkina1,4, Misha L Baker1,5, Koo-Whang Chung1, Richard A Henry6, James J Berger6, Matthew J Kuehnert1, Sridhar V Basavaraju1.   

Abstract

BACKGROUND: In 2011 and 2013, the National Blood Collection and Utilization Survey (NBCUS) revealed declines in blood collection and transfusion in the United States. The objective of this study was to describe blood services in 2015. STUDY DESIGN AND METHODS: The 2015 NBCUS was distributed to all US blood collection centers, all hospitals performing at least 1000 surgeries annually, and a 40% random sample of hospitals performing 100 to 999 surgeries annually. Weighting and imputation were used to generate national estimates for units of blood and components collected, deferred, distributed, transfused, and outdated.
RESULTS: Response rates for the 2015 NBCUS were 78.4% for blood collection centers and 73.9% for transfusing hospitals. In 2015, 12,591,000 units of red blood cells (RBCs) (95% confidence interval [CI], 11,985,000-13,197,000 units of RBCs) were collected, and 11,349,000 (95% CI, 10,592,000-11,747,000) were transfused, representing declines since 2013 of 11.6% and 13.9%, respectively. Total platelet units distributed (2,436,000; 95% CI, 2,230,000-2,642,000) and transfused (1,983,000; 95% CI, 1,816,000 = 2,151,000) declined by 0.5% and 13.1%, respectively, since 2013. Plasma distributions (3,714,000; 95% CI, 3,306,000-4,121,000) and transfusions (2,727,000; 95% CI, 2,594,000-2,859,000) in 2015 declined since 2013. The median price paid per unit in 2015-$211 for leukocyte-reduced RBCs, $524 for apheresis platelets, and $54 for fresh frozen plasma-was less for all components than in 2013.
CONCLUSIONS: The 2015 NBCUS findings suggest that continued declines in demand for blood products resulted in fewer units collected and distributed Maintaining a blood inventory sufficient to meet routine and emergent demands will require further monitoring and understanding of these trends.
© 2017 AABB.

Entities:  

Mesh:

Year:  2017        PMID: 28591469      PMCID: PMC5556921          DOI: 10.1111/trf.14165

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  37 in total

Review 1.  Evidence-based practice guidelines for plasma transfusion.

Authors:  John D Roback; Stephen Caldwell; Jeff Carson; Robertson Davenport; Mary Jo Drew; Anne Eder; Mark Fung; Marilyn Hamilton; John R Hess; Naomi Luban; Jeremy G Perkins; Bruce S Sachais; Aryeh Shander; Toby Silverman; Ed Snyder; Christopher Tormey; John Waters; Ben Djulbegovic
Journal:  Transfusion       Date:  2010-03-19       Impact factor: 3.157

2.  The Safety of the Blood Supply--Time to Raise the Bar.

Authors:  Edward L Snyder; Susan L Stramer; Richard J Benjamin
Journal:  N Engl J Med       Date:  2015-08-27       Impact factor: 91.245

3.  Implementation of a comprehensive blood conservation program can reduce blood use in a community cardiac surgery program.

Authors:  Steve Xydas; Christopher J Magovern; James P Slater; John M Brown; Rami Bustami; Grant V Parr; Robert L Thurer
Journal:  J Thorac Cardiovasc Surg       Date:  2012-01-27       Impact factor: 5.209

4.  Association Among Blood Transfusion, Sepsis, and Decreased Long-term Survival After Colon Cancer Resection.

Authors:  Christopher T Aquina; Neil Blumberg; Adan Z Becerra; Francis P Boscoe; Maria J Schymura; Katia Noyes; John R T Monson; Fergal J Fleming
Journal:  Ann Surg       Date:  2017-08       Impact factor: 12.969

Review 5.  Will pathogen reduction of blood components harm more people than it helps in developed countries?

Authors:  John R Hess; Monica B Pagano; James D Barbeau; Pär I Johannson
Journal:  Transfusion       Date:  2016-05       Impact factor: 3.157

Review 6.  Platelet transfusion: a systematic review of the clinical evidence.

Authors:  Ambuj Kumar; Rahul Mhaskar; Brenda J Grossman; Richard M Kaufman; Aaron A R Tobian; Steven Kleinman; Terry Gernsheimer; Alan T Tinmouth; Benjamin Djulbegovic
Journal:  Transfusion       Date:  2014-11-12       Impact factor: 3.157

7.  Reducing the financial impact of pathogen inactivation technology for platelet components: our experience.

Authors:  Enrique Girona-Llobera; Teresa Jimenez-Marco; Ana Galmes-Trueba; Josep Muncunill; Carmen Serret; Neus Serra; Matilde Sedeño
Journal:  Transfusion       Date:  2013-05-09       Impact factor: 3.157

8.  Allogeneic blood transfusions and postoperative infections after lumbar spine surgery.

Authors:  Stein J Janssen; Yvonne Braun; Kirkham B Wood; Thomas D Cha; Joseph H Schwab
Journal:  Spine J       Date:  2015-02-11       Impact factor: 4.166

9.  Variation in use of blood transfusion in coronary artery bypass graft surgery.

Authors:  Elliott Bennett-Guerrero; Yue Zhao; Sean M O'Brien; T B Ferguson; Eric D Peterson; James S Gammie; Howard K Song
Journal:  JAMA       Date:  2010-10-13       Impact factor: 56.272

10.  Collection and transfusion of blood and blood components in the United States, 1994.

Authors:  E L Wallace; W H Churchill; D M Surgenor; G S Cho; S McGurk
Journal:  Transfusion       Date:  1998-07       Impact factor: 3.157

View more
  61 in total

Review 1.  Shifting ground and gaps in transfusion support of patients with hematological malignancies.

Authors:  Christine Cserti-Gazdewich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population-based study.

Authors:  Eshan U Patel; Evan M Bloch; Mary K Grabowski; Ruchika Goel; Parvez M Lokhandwala; Patricia A R Brunker; Jodie L White; Beth Shaz; Paul M Ness; Aaron A R Tobian
Journal:  Transfusion       Date:  2019-06-20       Impact factor: 3.157

Review 3.  Transfusion-related red blood cell alloantibodies: induction and consequences.

Authors:  Christopher A Tormey; Jeanne E Hendrickson
Journal:  Blood       Date:  2019-02-26       Impact factor: 22.113

4.  Financial impact of alternative approaches to reduce bacterial contamination of platelet transfusions.

Authors:  Seema Kacker; Evan M Bloch; Paul M Ness; Eric A Gehrie; Christi E Marshall; Parvez M Lokhandwala; Aaron A R Tobian
Journal:  Transfusion       Date:  2019-01-08       Impact factor: 3.157

5.  Metabolic effect of alkaline additives and guanosine/gluconate in storage solutions for red blood cells.

Authors:  Angelo D'Alessandro; Julie A Reisz; Rachel Culp-Hill; Herbert Korsten; Robin van Bruggen; Dirk de Korte
Journal:  Transfusion       Date:  2018-04-06       Impact factor: 3.157

6.  Is surgical volume still the most accurate indicator of blood usage in the United States?

Authors:  Alexandra Savinkina; Mathew R P Sapiano; James Berger; Sridhar V Basavaraju
Journal:  Transfusion       Date:  2019-02-10       Impact factor: 3.157

7.  Analysis of Donor Safety in High Yield Plateletpheresis Procedures: An Experience from Tertiary Care Hospital in South India.

Authors:  Vijay Kumawat; Manu Goyal; Palniappan Marimuthu
Journal:  Indian J Hematol Blood Transfus       Date:  2020-02-27       Impact factor: 0.900

8.  Changes in Transfusion Coding Among Hospitalized Medicare Beneficiaries after Implementation of ICD-10.

Authors:  Eric D Weinhandl; Kristine M Kubisiak
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-16       Impact factor: 8.237

9.  Plateletpheresis-associated lymphopenia in frequent platelet donors.

Authors:  John M Gansner; Mahboubeh Rahmani; A Helena Jonsson; Brooke M Fortin; Idayat Brimah; Martha Ellis; Robin Smeland-Wagman; Zhihan J Li; Jason M Schenkel; Michael B Brenner; Revital Yefidoff-Freedman; Steven R Sloan; Nancy Berliner; Nicolas C Issa; Lindsey R Baden; Dan L Longo; Duane R Wesemann; Donna Neuberg; Deepak A Rao; Richard M Kaufman
Journal:  Blood       Date:  2018-11-14       Impact factor: 22.113

Review 10.  Red blood cell storage lesion: causes and potential clinical consequences.

Authors:  Tatsuro Yoshida; Michel Prudent; Angelo D'alessandro
Journal:  Blood Transfus       Date:  2019-01       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.